EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association between different atherogenic and insulin resistance indices and infertility in polycystic ovary syndrome patients

Kasra Jafari, Nazanin Azmi-Naei, Nooshan Tajik, Ashraf Moini, Amene Abiri iD

PLOS One · 22.05.2026 · 21 (5) · e0343783

DOI: 10.1371/journal.pone.0343783 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 22.05.2026. Verfasst von Kasra Jafari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Development Center, Arash Women's Hospital, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Insulin Resistance, Infertility, Female, Atherosclerosis. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to assess the association between multiple atherogenic and insulin resistance indices—including TyG, TyG-BMI, AIP, TG-HDL, and METS-IR—and infertility in women with PCOS, and to evaluate their clinical utility.

Methods

In this cross-sectional study, we analyzed data from 669 sexually active women aged 18–45 with PCOS treated at a tertiary center in Iran (2021–2023). We compared infertile women with PCOS (≥12 months unsuccessful conception, n = 274) to fertile women with PCOS (n = 395). Logistic regression, restricted cubic spline, and receiver operating characteristic (ROC) analysis were used to assess associations and predictive performance.

Results

Infertile women had significantly worse metabolic profiles across all indices (P < 0.001). AIP showed the largest point estimate of association (adjusted OR = 9.065, 95% CI: 1.722–47.721). TG-HDL showed a significant non-linear relationship, with ORs rising steeply up to a ratio of ~2.5. Predictive ability was modest, with AUCs ranging from 0.598 (TyG-BMI) to 0.625 (AIP, TG-HDL).

Conclusion

Several metabolic indices, particularly AIP, are associated with infertility in women with PCOS, though their standalone predictive utility remains limited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeInsulin ResistanceInfertility, FemaleAtherosclerosisHumansFemaleAdultCross-Sectional StudiesYoung AdultAdolescentMiddle AgedROC CurveBody Mass IndexIran

Autor:innen und Institutionen

  • Research Development Center, Arash Women's Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Epidemiology, School of Health, Iran University of Medical Sciences, Tehran, Iran.
  • Department of Epidemiology, School of Public Health, Shahroud University of Medical Sciences, Shahroud, Iran.
  • Department of Obstetrics and Gynecology, Arash Women's Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Obstetrics and Gynecology, Endocrinology and Female Infertility Unit, Arash Women's Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Breast Disease Research Center (BDRC), Tehran University Of Medical Sciences, Tehran, Iran.

ORCID-Profile: Amene Abiri

Zitieren

APA

Jafari, K., Azmi-Naei, N., Tajik, N., Moini, A., & Abiri, A. (2026). Association between different atherogenic and insulin resistance indices and infertility in polycystic ovary syndrome patients. PLOS One, 21(5), e0343783. https://doi.org/10.1371/journal.pone.0343783

Vancouver

Jafari K, Azmi-Naei N, Tajik N, Moini A, Abiri A. Association between different atherogenic and insulin resistance indices and infertility in polycystic ovary syndrome patients. PLOS One. 2026;21(5):e0343783. doi:10.1371/journal.pone.0343783

BibTeX
@article{Jafari2026,
  author = {Jafari, Kasra and Azmi-Naei, Nazanin and Tajik, Nooshan and Moini, Ashraf and Abiri, Amene},
  title = {Association between different atherogenic and insulin resistance indices and infertility in polycystic ovary syndrome patients},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {5},
  pages = {e0343783},
  doi = {10.1371/journal.pone.0343783}
}
Kostenlos starten →